Oxford BioDynamics Plc (OBD.L)
GBp 1.06
(13.03%)
GBp 1.06
(13.03%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -8.43 Million | -5.17 Million | -5.91 Million | -3.4 Million | -2.27 Million | -1.94 Million |
| Net Income | -10.82 Million | -7.56 Million | -7.62 Million | -4.91 Million | -3.38 Million | -2.42 Million |
| Depreciation & Amortization | 1.35 Million | 1.21 Million | 1.08 Million | 467 Thousand | 387 Thousand | 331 Thousand |
| Deferred income taxes | -3.71 Million | - | 502 Thousand | 655 Thousand | 380 Thousand | 513 Thousand |
| Stock-based compensation | 332 Thousand | 394 Thousand | 251 Thousand | 253 Thousand | 274 Thousand | 195 Thousand |
| Change in working capital | -671 Thousand | 999 Thousand | -213 Thousand | 236 Thousand | 270 Thousand | -472 Thousand |
| Other non-cash items | 5.08 Million | -216 Thousand | 83 Thousand | -102 Thousand | -196 Thousand | -86 Thousand |
| Investing Cash Flow | -691 Thousand | 1.25 Million | 2.82 Million | 4.58 Million | -11.18 Million | -678 Thousand |
| Investments in PPE | -716 Thousand | -901 Thousand | -3.08 Million | -457 Thousand | -632 Thousand | -776 Thousand |
| Acquisitions | - | -107 Thousand | - | 1000.00 | -422 Thousand | 12 Thousand |
| Investment purchases | - | 107 Thousand | - | -4.91 Million | -10.3 Million | - |
| Sales/Maturities of investments | 25 Thousand | 2.13 Million | 3.22 Million | 4.91 Million | 232 Thousand | - |
| Other Investing Activities | -395 Thousand | 14 Thousand | 2.69 Million | 5.03 Million | -67 Thousand | 86 Thousand |
| Financing Cash Flow | 13.42 Million | 2.56 Million | -804 Thousand | -181 Thousand | 236 Thousand | 10.03 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 14.14 Million | 3.62 Million | - | - | 236 Thousand | 10.04 Million |
| Other Financing Activities | -723 Thousand | -1.06 Million | - | - | - | -7000.00 |
| Accounts receivables | -448 Thousand | 469 Thousand | -560 Thousand | 136 Thousand | -14 Thousand | -100 Thousand |
| Accounts payables | -286 Thousand | 475 Thousand | 416 Thousand | 165 Thousand | 381 Thousand | -316 Thousand |
| Inventory | 63 Thousand | 55 Thousand | -69 Thousand | -80 Thousand | -97 Thousand | -56 Thousand |
| Other working capital | -286 Thousand | - | - | 15 Thousand | - | - |
| Cash at beginning of period | 974 Thousand | 2.17 Million | 6.11 Million | 5.19 Million | 18.27 Million | 10.79 Million |
| Cash at end of period | 5.25 Million | 974 Thousand | 2.17 Million | 6.11 Million | 5.19 Million | 18.27 Million |
| Capital Expenditure | -716 Thousand | -901 Thousand | -3.08 Million | -457 Thousand | -632 Thousand | -776 Thousand |
| Effect of forex changes on cash | -17 Thousand | 163 Thousand | -49 Thousand | -77 Thousand | 144 Thousand | 67 Thousand |
| Net cash flow / Change in cash | 4.27 Million | -1.2 Million | -3.94 Million | 921 Thousand | -13.08 Million | 7.48 Million |
| Free Cash Flow | -9.15 Million | -6.07 Million | -9 Million | -3.85 Million | -2.9 Million | -2.71 Million |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -4.72 Million | -10.82 Million | -6.38 Million | -4.44 Million | -7.56 Million | -3.68 Million |
| Depreciation & Amortization | 728 Thousand | 1.35 Million | 747 Thousand | 610 Thousand | 1.21 Million | 591 Thousand |
| Deferred income taxes | - | -3.71 Million | - | - | - | - |
| Stock-based compensation | - | 332 Thousand | - | - | 394 Thousand | - |
| Change in working capital | 782 Thousand | -671 Thousand | 539 Thousand | -1.21 Million | 999 Thousand | 958 Thousand |
| Other non-cash items | 335 Thousand | 5.08 Million | 2.89 Million | 2.19 Million | -216 Thousand | -710 Thousand |
| Investing Cash Flow | -292 Thousand | -691 Thousand | 1.97 Million | -2.66 Million | 1.25 Million | 1.21 Million |
| Investments in PPE | -292 Thousand | -716 Thousand | -455 Thousand | -261 Thousand | -901 Thousand | -297 Thousand |
| Acquisitions | - | - | -2.42 Million | - | -107 Thousand | -107 Thousand |
| Investment purchases | - | - | 2.4 Million | -2.4 Million | 107 Thousand | - |
| Sales/Maturities of investments | - | 25 Thousand | 25 Thousand | - | 2.13 Million | 1.61 Million |
| Other Investing Activities | - | - | 2.42 Million | - | 14 Thousand | - |
| Financing Cash Flow | -209 Thousand | 13.42 Million | 5.24 Million | 8.17 Million | 2.56 Million | -254 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 14.14 Million | 5.6 Million | 8.53 Million | 3.62 Million | - |
| Other Financing Activities | -209 Thousand | -723 Thousand | -362 Thousand | -361 Thousand | -1.06 Million | - |
| Accounts receivables | -19 Thousand | -448 Thousand | -152 Thousand | -296 Thousand | 469 Thousand | -58 Thousand |
| Accounts payables | 756 Thousand | -286 Thousand | 592 Thousand | -878 Thousand | 475 Thousand | 995 Thousand |
| Inventory | 45 Thousand | 63 Thousand | 99 Thousand | -36 Thousand | 55 Thousand | 21 Thousand |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 5.25 Million | 974 Thousand | 1.19 Million | 974 Thousand | 2.17 Million | 2.94 Million |
| Cash at end of period | 1.18 Million | 5.25 Million | 5.25 Million | 1.19 Million | 974 Thousand | 974 Thousand |
| Capital Expenditure | -292 Thousand | -716 Thousand | -455 Thousand | -261 Thousand | -901 Thousand | -297 Thousand |
| Effect of forex changes on cash | - | -17 Thousand | - | -17 Thousand | 163 Thousand | 136 Thousand |
| Net cash flow / Change in cash | -4.06 Million | 4.27 Million | 4.05 Million | 224 Thousand | -1.2 Million | -1.97 Million |
| Free Cash Flow | -3.84 Million | -9.15 Million | -3.61 Million | -5.53 Million | -6.07 Million | -3.36 Million |
SEBYF
MHLA
9552
BMOB3
OLECTRA
ONTRF